ConCallIQ
Go Pro
SHARDACROPCHEM Diversified 15 May 2026

Sharda Cropchem Ltd — Q4 FY26

Sharda Cropchem delivered a stellar Q4 FY26, with revenue growing 13% YoY to ₹2,065 crore, EBITDA surging 75% to ₹513 crore (margin 24.8%, up 750bps), and PAT rising 57% to ₹319...

bullish high
Compare with...
Revenue ₹2,065 Cr +13%
EBITDA ₹513 Cr +75%
PAT ₹319 Cr +57%
EBITDA Margin 24.8% +750bps
Duration 58 min
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Geopolitical uncertainty from Middle East war

The ongoing war in the Middle East creates uncertainty in supply chains and raw material availability, though no major impact seen yet.

medium · management_commentary
R

Raw material price increases from China

Potential spike in Chinese agrochemical prices could pressure margins, though management believes 80-90% can be passed on.

medium · analyst_question
R

Forex volatility impact on margins

Unrealized forex losses of ₹26 crore in Q4 highlight exposure to currency fluctuations, especially USD/EUR.

medium · analyst_question
R

Registration delays impacting new product launches

Bureaucratic delays in product registrations could slow revenue contribution from new molecules, though management downplays impact.

low · analyst_question